Clinical Resources for Clinicians · For clinicians
Thrombocytopenia in Pregnancy: Differential Diagnosis and Workup
Most thrombocytopenia in pregnancy is gestational thrombocytopenia: mild, second or third trimester, no bleeding, resolves after delivery. The differentials that matter are ITP, preeclampsia/HELLP, and the rare but dangerous thrombotic microangiopathies (TTP, atypical HUS). Timing, severity, blood pressure, the smear and a handful of labs separate them. Under the 2021 SOAP consensus, platelets of 70 × 10⁹/L or above are generally acceptable for neuraxial anesthesia.
In day-to-day practice the question usually arrives as a flagged CBC at the 28-week glucose visit: platelets 118, patient feels fine. Most of the time that's gestational thrombocytopenia and the job is to document it and recheck. The work is in recognizing the patients for whom it isn't.
Step one: confirm the count
Exclude pseudothrombocytopenia. EDTA-dependent platelet clumping produces falsely low counts. Look at the smear, and repeat in a citrate tube if clumping is seen. It's common, benign, and costs nothing to rule out, and it saves a patient an unnecessary hematology referral and a lot of worry.
The differential at a glance
| Cause | Typical timing | Severity | Key features |
|---|---|---|---|
| Gestational thrombocytopenia | Mid-2nd to 3rd trimester | Usually mild; rarely below ~70 × 10⁹/L | No bleeding; no prior history; resolves postpartum |
| Immune thrombocytopenia (ITP) | Any time; often 1st trimester or pre-existing | Any; can be severe | May have prior low counts; diagnosis of exclusion |
| Preeclampsia / HELLP | Usually > 20 weeks, often 3rd trimester or postpartum | Variable; can fall rapidly | Hypertension, raised LFTs, hemolysis (HELLP), proteinuria or end-organ signs |
| TTP | Any; often 2nd/3rd trimester or postpartum | Often severe | Microangiopathic hemolysis (schistocytes), neurologic or renal involvement; ADAMTS13 severely reduced |
| Atypical HUS | Often postpartum | Variable | Prominent acute kidney injury, microangiopathic hemolysis |
| Acute fatty liver of pregnancy | 3rd trimester | Variable | Liver failure, hypoglycemia, coagulopathy |
| DIC | Abruption, sepsis, amniotic fluid embolism, retained demise | Variable | Low fibrinogen, prolonged PT/aPTT |
| Secondary immune causes | Any | Variable | SLE, antiphospholipid syndrome, HIV, HCV, H. pylori |
| Drug-induced, including HIT | After exposure | Variable | Heparin 5–10 days after starting (HIT) is associated with thrombosis, not bleeding |
| Type 2B VWD, inherited thrombocytopenias | Pre-existing | Usually mild–moderate | Family history, abnormal platelet size, bleeding history |
| Marrow disorders, B12/folate deficiency | Any | Variable | Other cytopenias, abnormal smear |
The most useful single data point is often the oldest one. Pull any pre-pregnancy CBC you can find, including from the patient's primary care portal. A normal count two years ago points one way; a count of 95 at her last physical points another.
Gestational thrombocytopenia
Per ACOG Practice Bulletin 207, gestational thrombocytopenia:
- Is the most common cause of thrombocytopenia in pregnancy
- Usually produces only a mild drop; a count below about 70 × 10⁹/L should prompt a search for another cause
- Typically appears in the mid-second to third trimester
- Isn't associated with maternal bleeding or with fetal or neonatal thrombocytopenia
- Resolves spontaneously after delivery, usually within weeks
Management: monitoring only. Recheck periodically through the third trimester and as delivery approaches, and confirm normalization postpartum. If the count hasn't recovered, the diagnosis was probably ITP. That postpartum CBC is the step most often skipped; build it into the postpartum order set.
Immune thrombocytopenia
ITP has no confirmatory test, and antiplatelet antibody assays aren't recommended. Suspect it when:
- Thrombocytopenia predates pregnancy or appears in the first trimester
- Counts are below about 70 × 10⁹/L
- Counts fall progressively across pregnancy
- There's a history of autoimmune disease
Workup
- CBC, smear and reticulocytes
- HIV and HCV testing; consider H. pylori
- LFTs, blood pressure and urine protein to exclude preeclampsia
- Antiphospholipid antibodies and ANA if clinically suggestive
- Thyroid function where relevant
Treatment thresholds
ACOG and the hematology guidelines broadly agree:
- Treat for bleeding, for platelets below about 30 × 10⁹/L, or to reach a safe count for delivery and neuraxial anesthesia.
- First-line: corticosteroids (prednisone) or IVIG. IVIG acts faster and is preferred when a rapid rise is needed or steroids are poorly tolerated, for example with gestational diabetes or hypertension.
- Refractory cases: combinations or second-line agents should be hematology-led. Several agents are avoided in pregnancy.
- Delivery: mode is determined by obstetric indications, because cesarean doesn't reduce the risk of neonatal intracranial hemorrhage. Many teams avoid fetal scalp electrodes and operative vaginal delivery where possible. Check neonatal platelets, since maternal antibodies cross the placenta.
Preeclampsia and HELLP
Thrombocytopenia below 100 × 10⁹/L is a severe feature of preeclampsia under ACOG Practice Bulletin 222. In HELLP, counts can fall quickly, so SOAP recommends a platelet count within 6 hours before a neuraxial procedure. Treatment is delivery. Platelets usually bottom out within about 24 to 48 hours postpartum and then recover. Persistent or worsening thrombocytopenia beyond that window should raise concern for TTP or atypical HUS.
Thrombotic microangiopathies: don't miss these
Red flags: schistocytes on the smear, raised LDH, low haptoglobin, a negative DAT, neurologic symptoms or renal injury, especially when out of proportion to blood pressure or persisting after delivery.
- Send ADAMTS13 activity before any plasma is given.
- Involve hematology emergently. Suspected TTP is treated with plasma exchange, which shouldn't wait for the ADAMTS13 result.
- Atypical HUS is complement-mediated and treated with complement inhibition.
Plasma exchange isn't available at every delivering hospital. If you practice at a community unit, know your transfer pathway in advance; in New York that's often the Regional Perinatal Center or an affiliated tertiary hospital in your network.
Pregnancy can unmask both congenital and acquired TTP, and patients with a history of TTP need hematology planning before conception. Our hematology referral checklist lists platelet-related referral triggers, and VWD in pregnancy covers type 2B VWD, an easy-to-miss cause of thrombocytopenia.
Neuraxial thresholds (SOAP 2021)
| Platelet count | SOAP consensus (GT, ITP, hypertensive disorders, no other risk factors) |
|---|---|
| ≥ 70 × 10⁹/L | Risk of spinal epidural hematoma likely very low; reasonable to proceed |
| 50–70 × 10⁹/L | Individualize; may be reasonable when benefits outweigh risks |
| < 50 × 10⁹/L | Risk likely increased; reasonable to avoid |
The consensus was endorsed by ACOG, SMFM and ASRA. It assumes no coagulopathy, no antiplatelet or anticoagulant therapy, and a stable count. A bleeding history or suspected coagulopathy changes the calculation, so bring anesthesia in early, ideally with an antenatal consult rather than a 2 a.m. conversation in triage.
Fetal and neonatal considerations
- GT carries no fetal risk.
- Maternal ITP can cause neonatal thrombocytopenia. Check cord or neonatal platelets and alert pediatrics.
- Fetal/neonatal alloimmune thrombocytopenia (FNAIT) results from maternal alloantibodies, usually against HPA-1a, in a mother with a normal count. A prior affected pregnancy calls for MFM and hematology management next time, given the significant recurrence risk.
A practical monitoring schedule
For presumed gestational thrombocytopenia, many teams recheck platelets every few weeks in the third trimester and again on admission for delivery. Suspected ITP needs more frequent counts as delivery approaches, often weekly from about 34 to 36 weeks, so treatment can be timed to reach a safe count for neuraxial anesthesia.
Documentation for L&D
Put the working diagnosis, the trend, the latest count with its date, and the neuraxial plan where the admitting team will see it, not buried in a scanned consult note. When the cause is still uncertain at admission, document the differential and the specific results (smear, LFTs, blood pressure trend) to recheck if the count falls further. In large groups where the delivering clinician may never have met the patient, this one note does a lot of work.
Referral partnership in New York
Platelets persistently below 100 × 10⁹/L, early-onset thrombocytopenia, suspected ITP, or counts that may affect neuraxial planning all benefit from early hematology input. Premier Hematology & Oncology, which sponsors our professional resources, offers referral pathways and co-management for thrombocytopenia in pregnancy, plus fast-track IV iron scheduling for patients who also have iron deficiency. See our hematology partners page.
Frequently asked questions
What is the most common cause of low platelets in pregnancy?
Gestational thrombocytopenia, which is mild, appears in the second or third trimester, causes no bleeding and resolves after delivery. It's a diagnosis of exclusion.
How do you tell gestational thrombocytopenia from ITP?
There's no definitive test. ITP is more likely when counts are below about 70 × 10⁹/L, thrombocytopenia appears early in pregnancy or before it, or the patient has a history of low platelets outside pregnancy.
What platelet count is safe for an epidural?
The 2021 SOAP consensus, endorsed by ACOG and SMFM, states that neuraxial procedures are reasonable at counts of 70 × 10⁹/L or above in gestational thrombocytopenia, ITP or hypertensive disorders without other risk factors.
When should ITP be treated in pregnancy?
Treatment is generally indicated for bleeding, for platelet counts below about 30 × 10⁹/L, or to raise counts for delivery and neuraxial anesthesia. Corticosteroids and IVIG are first-line.
Sources
- ACOG — Thrombocytopenia in Pregnancy (Practice Bulletin No. 207)
- SOAP — Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients With Thrombocytopenia (2021)
- ASH — 2019 guidelines for immune thrombocytopenia
- ACOG — Gestational Hypertension and Preeclampsia (Practice Bulletin No. 222)
- International consensus report on the investigation and management of primary immune thrombocytopenia
This article is for general education and is not medical advice. It does not replace an evaluation by a licensed clinician who knows your history. If you think you have a medical emergency, call 911.